Overview
- On Nov. 2, Scott Adams asked President Trump on X to help secure a scheduled IV infusion of Pluvicto after saying Kaiser Permanente–Northern California approved the drug but had not set an appointment.
- Trump replied "On it" on Truth Social as HHS Secretary Robert F. Kennedy Jr. sought contact with Adams, and White House aide Dan Scavino said Trump, Kennedy and CMS Administrator Mehmet Oz were tracking the case.
- STAT reported, citing an unnamed source, that Trump called Oz, who then spoke with Adams and Kaiser representatives and that Kaiser planned to quickly resolve the scheduling.
- Kaiser Permanente said Adams’ oncology team is working closely with him and that next steps are underway, noting it has treated more than 150 Northern California patients with Lu‑177 PSMA (Pluvicto) since 2022.
- By Nov. 3, Adams posted that he was "so grateful" and "getting what I need now," though public details about specific administrative actions or the timing of the infusion remain limited.